Revenue declined 4.9% year over year and rose 13.4% sequentially. Margins improved from the previous quarter, suggesting stronger cost discipline and operational efficiency. Abbvie Inc also posted year-over-year earnings growth, reinforcing a more resilient operating profile.
Revenue remains weak year over year, but sequential improvement suggests near-term stabilization.
Margins improved from last quarter, suggesting that cost controls are starting to offset topline weakness.
The earnings story is shifting from pure growth toward efficiency, pricing discipline, and margin defense.
Revenue trend and year-over-year growth across recent reported quarterly periods.
Net income and net margin trend over recent reported quarterly periods.
Abbvie Inc reported $13.9B in revenue for Q2 2023, down 4.9% YoY and up 13.4% QoQ. The result suggests that although topline pressure remains, quarterly demand may be starting to stabilize.
Net income came in at $2.0B, up 119% YoY and up 746.9% QoQ. Net margin was 14.6%. Sequential margin improvement suggests stronger operating discipline despite a mixed revenue environment.
Quick factual answers for this report. Need the why behind them? Ask the report assistant.
Abbvie Inc reported revenue of $13.9B in Q2 2023.
Abbvie Inc reported net income of $2.0B in Q2 2023.
Abbvie Inc's revenue decreased by 4.9% year over year in Q2 2023.
Abbvie Inc's net margin was 14.6% in Q2 2023.
Compare this quarter with the previous earnings report.
Explore company profile, industry, and historical context.
View more quarterly financial trend pages for this company.
Financial data is sourced from company filings and internal processed earnings data.
YoY and QoQ values are derived from reported quarterly figures when not directly available.
This page is for informational purposes only and does not constitute investment advice.